APA (7th ed.) Citation

Kuboki, Y., Arkenau, H., Subbiah, V., Price, T., Falchook, G., Prenen, H., . . . Kistler, M. A phase I, open-label, multicentre, first-in-human study to evaluate safety, pharmacokinetics and efficacy of AMG 404, a PD-1 inhibitor, in patients with advanced solid tumours. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Kuboki, Yasutoshi, et al. A Phase I, Open-label, Multicentre, First-in-human Study to Evaluate Safety, Pharmacokinetics and Efficacy of AMG 404, a PD-1 Inhibitor, in Patients with Advanced Solid Tumours. BMJ Publishing Group.

MLA (9th ed.) Citation

Kuboki, Yasutoshi, et al. A Phase I, Open-label, Multicentre, First-in-human Study to Evaluate Safety, Pharmacokinetics and Efficacy of AMG 404, a PD-1 Inhibitor, in Patients with Advanced Solid Tumours. BMJ Publishing Group.